MAPT and Alzheimer disease: Based on this evidence, it is conceivable that 11C-PBB3 binds preferentially to tau deposits located in close proximity to the abundant amyloid-beta plaques in the early symptomatic stages of AD examined in this study, while 11C-THK5351 appears to bind to a wider range of tau deposits [43], based on the regional distribution of the tracer.